Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas - Wikidata - wikimedia - TriplyDB

Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas

Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas

http://www.wikidata.org/entity/Q33193334

about

GLEPP1/protein-tyrosine phosphatase phi inhibitors block chemotaxis in vitro and in vivo and improve murine ulcerative colitis Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia Downregulation of miR-122 in the rodent and human hepatocellular carcinomas Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis Protein tyrosine phosphatase receptor-type O (PTPRO) is co-regulated by E2F1 and miR-17-92 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal A folate- and methyl-deficient diet alters the expression of DNA methyltransferases and methyl CpG binding proteins involved in epigenetic gene silencing in livers of F344 rats Identification of T-cadherin as a novel target of DNA methyltransferase 3B and its role in the suppression of nerve growth factor-mediated neurite outgrowth in PC12 cells DNA methyltransferase 3b regulates nerve growth factor-induced differentiation of PC12 cells by recruiting histone deacetylase 2 Role of protein tyrosine phosphatases in cancer The protein tyrosine phosphatase receptor type R gene is an early and frequent target of silencing in human colorectal tumorigenesis Choline, Other Methyl-Donors and Epigenetics.Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients.Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma.Lyn kinase and ZAP70 are substrates of PTPROt in B-cells: Lyn inactivation by PTPROt sensitizes leukemia cells to VEGF-R inhibitor pazopanib DNA methylation of cancer genome.Metastatic suppressor genes inactivated by aberrant methylation in gastric cancer.Protein tyrosine phosphatase receptor-like genes are frequently hypermethylated in sporadic colorectal cancer.Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancer.Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate.Reduced susceptibility of DNA methyltransferase 1 hypomorphic (Dnmt1N/+) mice to hepatic steatosis upon feeding liquid alcohol diet.Epigenetic regulation of protein tyrosine phosphatases: potential molecular targets for cancer therapy.LINE-1 hypomethylation in a choline-deficiency-induced liver cancer in rats: dependence on feeding period.Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies.Aberrant methylation of the PTPRO gene in peripheral blood as a potential biomarker in esophageal squamous cell carcinoma patients.PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: an emphasis on fetal-based adult diseases.Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation Targeting the PTPome in human disease.Protein-tyrosine phosphatases and cancer.Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: studies in rodents.Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity Role of protein-tyrosine phosphatases in regulation of osteoclastic activity.PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt.PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2 Role of estrogen in hepatocellular carcinoma: is inflammation the key?

P2860

Q24313112-6DDF11B7-518B-4F82-887E-27D3BF1315E2 Q24564615-FDDECA16-A643-43FE-9656-7B9F7F32CA49 Q24619893-80641379-35A7-44A5-B895-75931862BF4C Q24631076-3F24CE4A-86D9-40FD-8DEF-96C70163294F Q24656948-CCFB4D23-56AB-42B6-B73C-FA1BDE10B606 Q28288074-E6AFD017-9B3F-47CD-90A1-5477500B6B59 Q28384242-25EDE629-BF7F-44FB-A67B-8182CF5F616A Q28566367-C9609B44-1F99-42D6-815F-FE8F83320F45 Q28580458-568B5571-370A-43AB-A9D3-DFCD610134CD Q28584099-46CB1D76-92B1-4554-9B68-13F8A08A5558 Q28741003-B3187CB8-EF52-4DA3-8072-514586722FFD Q33571397-1A3188EC-F539-4441-9097-407069650D98 Q33749246-483BB722-83E4-4DDE-8605-47A11AC9207B Q33775528-22DE8C3B-AFB1-496F-BDB7-85C77BCF4B7B Q33828327-837E6FF4-21AC-435D-85AD-B11C6CB3248C Q33952692-F6D84916-1DF5-4C87-AB29-785BC3B76AAD Q34133706-6AD367EC-332C-4D5F-BB42-38486929B3F8 Q34225341-56E6DF4A-7620-4258-ACCE-6C1A2DF29A60 Q34308099-D10CC27F-2DF4-40A3-953F-7DD680A2B71A Q34336836-BE505192-9CBF-42E0-8924-AF3FFDB112AA Q34349289-9E5E0FDE-36BA-48B1-A8DC-1B16ACB86371 Q34384312-96E3A4C3-16FD-4C0C-B0FD-3E0C89CDC73C Q34528296-B5F1E18C-5EB7-4B31-B4DC-21AC7CF4809A Q34684583-23C8A35C-7CEB-4F9C-98DF-9F3A654F4EC5 Q35553581-45246785-C45F-455B-A988-EAA1DDCF6C8A Q35643156-1FB658C1-AF08-4996-AFE0-B4188F24ED3B Q35685290-08FF8693-242B-4692-9118-295E9E7A4049 Q35832384-88162FCB-7190-4234-AABF-16108E0FD0BD Q36108445-30F9A299-43C3-483D-AF81-0973178C4BCC Q36277279-9789E416-91E9-4C88-A923-EBC95CA2EADE Q36379394-965E9A96-F9F5-4777-82B6-EADC96A7D7DA Q36430193-3EDF7AC3-80EA-4135-BAAD-F2744F2F0C58 Q36459023-4FA9EDAF-230B-4FD7-9739-2BCBAA3D6E36 Q36945640-5384AFD7-C0A2-41C0-A0DD-94DC30A3AA42 Q37106891-AB5294D8-6CCA-4B11-9FE4-6DE97D99146E Q37263070-55597883-A900-4E19-A3C2-77354AC3A8BC Q37367387-5C51729A-9A24-49C9-B512-3BA5FAA33742 Q37484499-6410D612-30B9-4FE8-9E71-EBE019BA78B8 Q37609203-C54E65A7-30FE-45D5-A733-455FFCB46E6F Q37710885-3974E1E8-3734-4E58-86AC-3D9E0C4C045A

P2860

Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas

http://www.wikidata.org/entity/Q33193334

description

2003 nî lūn-bûn

@nan

2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Suppression of the protein tyr ...... n in hepatocellular carcinomas

@ast

Suppression of the protein tyr ...... n in hepatocellular carcinomas

@en

type

label

Suppression of the protein tyr ...... n in hepatocellular carcinomas

@ast

Suppression of the protein tyr ...... n in hepatocellular carcinomas

@en

prefLabel

Suppression of the protein tyr ...... n in hepatocellular carcinomas

@ast

Suppression of the protein tyr ...... n in hepatocellular carcinomas

@en

P1433

Q33193334-08224C1C-E684-4A99-BA0B-B82F78B6D70F

P1476

Q33193334-480E232D-A65A-4F87-807E-49A7641BF099

P2093

Q33193334-0FBBF08B-DB2E-46DC-902E-9FA0F68E38BD

Q33193334-14EC5B58-55D5-4389-81BE-4E6E509CF033

Q33193334-31C26228-5610-4D9C-8F9F-EE95FDF8BCDC

Q33193334-410D6EC5-4580-4935-B66D-9E5D9B3946C3

Q33193334-4D032ADD-59BF-4BD3-9633-5ABD82D7CD58

Q33193334-74B9B53A-057C-4611-9F55-69A2DC5C22DB

Q33193334-878528F2-A01E-4401-8DCD-7FD247F90898

Q33193334-89238BA2-F69A-4862-8137-3A72278B5AEC

Q33193334-90C037A6-61CE-45D1-8CCF-78122236889A

Q33193334-A1824D93-B0F0-499C-BF0B-2D6B627B0B93

P2860

Q33193334-02ACA511-B6A4-4426-9777-2EC6573F66D1

Q33193334-03A8DFB0-60EE-41F1-A2E7-F7429653C7FD

Q33193334-08565648-8BD7-446D-B383-D0F475A7089D

Q33193334-0ACAA460-755F-4513-ADDC-9C62AA65E3B7

Q33193334-0B995DEB-73CB-40D4-B4AA-9EF3BF2AE466

Q33193334-15B325D6-A6AA-458E-ACF2-7AEB80370099

Q33193334-1A6339A7-1F26-4461-802F-7888B5B1EACF

Q33193334-1DAFA268-C3A8-49E7-AFDA-4301159093E6

Q33193334-23ED476F-2350-48A8-9FA3-A3D1F324562F

Q33193334-26DEF8AA-68CD-4BDE-B95A-FA92721E2E93

P2888

Q33193334-82FF185A-8D44-43F8-B70D-CD100D0F1187

P304

Q33193334-FDF71475-2B24-4B16-B681-7B8DDBAD2208

P31

Q33193334-5489CEFA-0064-42AE-98A2-35500E57B9CE

P356

Q33193334-EFC8FC9A-CAC7-44DA-BDA8-3496DDA3E39B

P407

Q33193334-28DF4ED3-BD30-4529-B754-747E395F0727

P433

Q33193334-A777FD1C-C0AE-4D63-BAFC-091EA724E929

P478

Q33193334-007678A7-4503-41D7-AB17-5CF4D4287EE3

P577

Q33193334-86F62598-93A6-4F5C-BF06-6555C20225FF

P5875

Q33193334-C6029380-1C87-4979-B0DB-F067E25B8EAD

P6179

Q33193334-D2666281-FB43-4A33-8223-EC317D0E2D99

P698

Q33193334-96FC4414-8B90-4641-B45A-86A1819335F6

P932

Q33193334-685775D4-2AAC-4D42-9CC8-01486C40E011

P356

P1433

P1476

Suppression of the protein tyr ...... n in hepatocellular carcinomas

@en

P2093

Anindita Das

http://www.w3.org/2001/XMLSchema#string

Christoph Plass

http://www.w3.org/2001/XMLSchema#string

Dieter Weichenhan

http://www.w3.org/2001/XMLSchema#string

Kalpana Ghoshal

http://www.w3.org/2001/XMLSchema#string

Kristen Holman

http://www.w3.org/2001/XMLSchema#string

S Jill James

http://www.w3.org/2001/XMLSchema#string

Samson T Jacob

http://www.w3.org/2001/XMLSchema#string

Sarmila Majumder

http://www.w3.org/2001/XMLSchema#string

Tasneem Motiwala

http://www.w3.org/2001/XMLSchema#string

Yue-Zhong Wu

http://www.w3.org/2001/XMLSchema#string

P2860

PTPROt: an alternatively spliced and developmentally regulated B-lymphoid phosphatase that promotes G0/G1 arrest

Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene

Molecular cloning of cDNAs encoding human GLEPP1, a membrane protein tyrosine phosphatase: characterization of the GLEPP1 protein distribution in human kidney and assignment of the GLEPP1 gene to human chromosome 12p12-p13

The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome

CpG island methylator phenotype in colorectal cancer

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Serial analysis of gene expression

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling

A phosphatase associated with metastasis of colorectal cancer

P2888

P304

6319-6331

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1206750

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9080521

http://www.w3.org/2001/XMLSchema#string

P6179

1019355024

http://www.w3.org/2001/XMLSchema#string

P698

14508512

http://www.w3.org/2001/XMLSchema#string

P932

3020652

http://www.w3.org/2001/XMLSchema#string